FERRONATO-KGS-GROUP
24.1.2022 17:52:12 CET | Business Wire | Press release
The Swiss technology company FERRONATO KGS GROUP , which specialises in industrial metallised fabrics, forayed into the lifestyle domain with the global launch of a new smart accessories brand – FERRONATO – at the Swiss Pavilion , Expo 2020 Dubai .
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220124005556/en/
"We have always been acknowledged for its focus on innovation tech and the new personal lifestyle accessories brand, Ferronato, is yet another milestone in our journey," said Sandro Giovanni Ferronato, CEO, FERRONATO KGS GROUP LTD.
FERRONATO KGS GROUP was established in 1906 in Lugano, Switzerland. World-renowned for its precision tools, abrasives and metallised fabrics, KGS is now helmed by a 3rd generation, led by Sandro Giovanni Ferronato.
He added, "Ferronato is a lifestyle brand borne out of a sense of immediacy that creates bespoke, high-end accessories that aim to protect your privacy.”
The Ferronato smart accessories showcased at the Swiss Pavilion include a range of personal products powered by KGS metallised fabrics, including laptop sleeves, phone pouches, totes, and briefcases that ensure the protection of privacy and personal information.
The company said the smart accessories made of metallised fabrics fit in well as an antidote to invasive surveillance threats people face at every step of their personal life.
"These smart accessories, made for our digital life, safeguard from several potential digital threats. This includes from stopping tracking of our location, remote activation of our phone to eavesdropping on our conversations to steal critical information and personal data," said Alessia Ferronato, Partner, Ferronato.
KGS said that these accessories will curb hacking, tracking, potential cybercrimes, data theft, digital infiltration and system breeches without the consent of an individual or individuals.
As the world's leading manufacturer of flexible diamond abrasives and electrolytically metallised fabrics, KGS’ industrial products are used across many industry verticals. This includes aerospace, aeronautical, defence, automotive, medical equipment, construction, telecommunications and consumer electronics.
The company, with offices in 16 countries, has been supplying products in over 100 countries from its six manufacturing sites in Switzerland, The Netherlands, Hungary, Portugal, United Arab Emirates, China and India.
For more information, please visit https://www.kgs.swiss/ and https://www.ferronato.swiss/
Instagram: https://www.instagram.com/ferronato.swiss/
Facebook: https://www.facebook.com/ferronato.swiss
*Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20220124005556/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Office of His Highness Sheikh Hamdan Bin Ahmed Al Maktoum Holdings & Gatbits IT Infrastructure Announce Launch of GTBS Digital Ecosystem; Mainnet Set for April 202630.3.2026 20:30:00 CEST | Press release
The Office of His Highness Sheikh Hamdan Bin Ahmed Al Maktoum Holdings, in collaboration with Gatbits IT Infrastructure, has officially announced the launch of the GTBS Digital Ecosystem, marking a significant step forward in the global Web3 space. The announcement follows the successful launch of the native GTBS Coin on December 25, with the ecosystem’s mainnet scheduled to go live in April 2026. GTBS represents a full-stack Web3 ecosystem integrating blockchain, artificial intelligence, decentralized finance (DeFi), entertainment, gaming, media, and cloud infrastructure into a unified platform. Built on the philosophy of “All Commitment On Time,” the ecosystem focuses on delivering reliability, scalability, and real-world utility. Designed as a comprehensive digital infrastructure, GTBS goes beyond standalone crypto platforms by offering an integrated environment for users, developers, creators, and enterprises. Its proprietary Layer-1 blockchain powers seamless interaction across se
Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 15:00:00 CEST | Press release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release
Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom